Developmental changes in human gamma-aminobutyric acidA receptor subunit composition

Area of Science:

• Neuroscience
• Developmental Biology
• Pharmacology

Background:

• Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the human central nervous system.
• GABA-A receptors are crucial drug targets, notably for benzodiazepines.
• Multiple GABA-A receptor subtypes exist, with developmental regulation observed in rodents.

Purpose of the Study:

• To investigate the developmental changes in GABA-A receptor subtypes in human brain tissue.
• To compare receptor composition at birth versus adulthood.
• To understand the implications for neurodevelopment and neurological disorders.

Main Methods:

• Analysis of postmortem human cerebellum and cerebral cortex tissue.
• Benzodiazepine receptor binding studies.
• Comparison with recombinant human GABA-A receptors.
• Measurement of alpha 1 subunit messenger RNA (mRNA) levels.

Main Results:

• GABA-A receptors increase threefold in the human cerebellum from birth to adulthood.
• Two benzodiazepine receptor subtypes are present in neonates, decreasing to one in adults.
• Receptors containing the alpha 1 subunit increase from 50% at birth to over 95% in adults.
• Significant increases in alpha 1 mRNA were observed in both cerebellum and cortex during development.

Conclusions:

• The complement of GABA-A receptors undergoes substantial changes during human brain development.
• These developmental shifts, particularly involving the alpha 1 subunit, are critical for normal neurodevelopment.
• Understanding these changes is vital for treating conditions like seizures and other pathophysiological states.